Tuesday, September 13, 2016

BRIEF-Exelixis says European commission approves Cabometyx

* European Commission approves Cabometyx tablets for the

treatment of advanced renal cell carcinoma following

VEGF-targeted therapy

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)